Review
Aug 2026
Finerenone in Heart Failure with Preserved Ejection Fraction: Expanding the Role of Non-steroidal Mineralocorticoid Receptor Antagonists
Finerenone is a promising therapy for HFpEF/HFmrEF, particularly in patients with the cardiovascular-kidney-metabolic syndrome (CKM).
A. Khidhir, D. Kalra
· Current Atherosclerosis Repo... · 0 citations